Head and neck cancer registry for adult patients
Part of Cancer, Ear, nose & throat, Lungs & breathing, Mouth & dental clinical trials.
This study builds a European database (registry) of adults with certain head and neck cancers to better understand how these cancers are diagnosed and treated over time. It may help future care by collecting real-world information, rather than testing a new medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have a head and neck epithelial tumor in specific areas (nasopharynx, nose/sinuses, salivary glands, middle ear, throat areas, or mouth/lip)
- Your cancer diagnosis must be confirmed or entered by an expert cancer center
- You can join at any stage—at diagnosis, during first treatment, for recurrence, or for treatment of spread
- You must be (or have been) managed and actively followed by the hospital/center starting in 2021, or have care with diagnosis back to no earlier than 2018
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genetic information in your tumor to find new ways to treat head and neck cancer. You'll get extra biopsies and blood tests, and your genetic data will be shared with researchers to help personalize future treatments.
This trial collects tissue and health information to find the best treatment for your head and neck cancer. It may help guide your care by looking at the genetic details of your tumor.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
This registry collects information from Italian hospitals about people with head and neck cancers. By joining, you help doctors better understand the disease and improve future treatments.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.